Difficulty: Medium
Average Score: 80%
Practice
A 32-year-old G2P1001 woman at 36 weeks gestation presents to the emergency room with a high fever. The fever started 2 days ago and has progressively worsened. It has been associated with chills, nausea, vomiting, and full body aches. The resident suggests starting trimethoprim-sulfamethoxazole as part of the empiric coverage of her infection until blood cultures return. What side effect would be a contraindication to starting trimethoprim-sulfamethoxazole in a pregnant woman?
Correct answer
D
Rationale
The correct answer is D) Kernicterus. Kernicterus is a serious condition caused by the buildup of bilirubin in the brain, leading to neurological damage. Trimethoprim-sulfamethoxazole can displace bilirubin from albumin, increasing the risk of kernicterus in newborns. In this case, the pregnant woman being at 36 weeks gestation is close to term, and the concern is for the impact on the newborn.
Option A) Cartilage damage in fetus is incorrect as it is associated with fluoroquinolones, not trimethoprim-sulfamethoxazole. Option B) Discoloration of teeth is associated with tetracyclines. Option C) Gray baby syndrome is associated with chloramphenicol use in neonates, not trimethoprim-sulfamethoxazole.
Educationally, it is crucial to understand the potential side effects and contraindications of medications, especially in vulnerable populations like pregnant women. This case highlights the importance of considering both the maternal and fetal implications when making treatment decisions during pregnancy. Healthcare providers must weigh the risks and benefits of medications to ensure the safety of both the mother and the baby.
Option A) Cartilage damage in fetus is incorrect as it is associated with fluoroquinolones, not trimethoprim-sulfamethoxazole. Option B) Discoloration of teeth is associated with tetracyclines. Option C) Gray baby syndrome is associated with chloramphenicol use in neonates, not trimethoprim-sulfamethoxazole.
Educationally, it is crucial to understand the potential side effects and contraindications of medications, especially in vulnerable populations like pregnant women. This case highlights the importance of considering both the maternal and fetal implications when making treatment decisions during pregnancy. Healthcare providers must weigh the risks and benefits of medications to ensure the safety of both the mother and the baby.